Regular Article
Ischemic Preconditioning and Morphine-induced Cardioprotection Involve the Delta (δ)-opioid Receptor in the Intact Rat Heart

https://doi.org/10.1006/jmcc.1997.0454Get rights and content

Abstract

Several investigators have demonstrated that the opioid pathway is involved in tissue preservation during hypoxia or ischemia and that this protection is mediated via the delta (δ)-opioid receptor. Subsequently, we have shown that opioid receptors are involved in ischemic preconditioning (PC) in the rat heart and that morphine produces a cardioprotective effect; however, the class of opioid receptors involved in mediating these effects is still unknown. Therefore, the purpose of the present study was to test the hypothesis that ischemia- and morphine-induced cardioprotection are mediated via stimulation of theδ-opioid receptor in the rat heart. Anesthetized, open-chest Wistar rats were subjected to one of six protocols. The control group was subjected to 30 min of occlusion and 2 h of reperfusion. Ischemic PC was elicited by three 5 min occlusion periods interspersed with 5 min of reperfusion. Morphine-induced cardioprotection was produced by three 5 min morphine infusions (100μg/kg/infusion, i.v.) interspersed with a 5-min drug-free period. To determine if theδ-opioid receptor has a role in ischemic PC and morphine-induced cardioprotection, naltrindole (NTI), a selectiveδ-opioid receptor antagonist, was utilized. NTI (5 mg/kg, i.v.) was given 10 min prior to ischemic PC (NTI+PC) or morphine infusion (NTI+MOR). Also, NTI (5 mg/kg, i.v.) was given 10 min before the 30 min occlusion period in untreated rats. Infarct size (IS) as a percent of the area at risk (AAR) was determined by 2,3,5-triphenyltetrazolium chloride staining. Ischemic PC and morphine infusions resulted in similar reductions in IS/AAR from 51±4 to 11±3 and 15±4% (*P<0.05), respectively. NTI completely abolished the cardioprotective effect induced by ischemia and morphine. The results of the present study suggests a role ofδ;-opioid receptors in ischemic PC or morphine-induced myocardial protection in the rat.

References (0)

Cited by (241)

  • Impact of timing of morphine treatment on infarct size in experimental animal model of acute myocardial ischemia and reperfusion

    2022, European Journal of Pharmacology
    Citation Excerpt :

    Although opioid κ and δ receptors dominate the heart (Ventura et al., 1989; Wittert et al., 1996), expressions of opioid μ receptor (MOR), κ receptor (KOR) and δ receptor (DOR) were found in human heart tissues, including the myocardial cells, ICA cells and sensory nerves (Sobanski et al., 2014) and in rat cardiac sarcolemma, intracellular caveolin-3-associated microdomain of adult rat heart (Ventura et al., 1989; Head et al., 2005) and in dorsal root ganglia (Ji et al., 1995; Endres-Becker et al., 2007; Snyder et al., 2018). Here in this study, the cardioprotective effect of morphine was completely reversed by CTAP, norBNI and NTI, indicating that opioid μ, κ and δ receptors were involved in mediation of the cardioprotective effects induced by intravenously injected morphine (0.3 mg/kg) giving at 15 min before induction of myocardial ischemia and reperfusion, as reported previously (Schultz et al., 1995, 1997a, 1997b; Miki et al., 1998; Zhang et al., 2004; Li et al., 2009). Myocardial ischemia may play a role of kick point.

  • Morphine and myocardial ischaemia-reperfusion

    2021, European Journal of Pharmacology
    Citation Excerpt :

    Morphine preconditioning (MPC) is initiated by three 5-min or 3-min intravenous drug administrations interspersed with 5-min drug-free periods (Schultz et al., 1996; Wang et al., 1998) or a single intravenous injection of morphine (Gross et al., 2006; Okubo et al., 2004) before prolonged myocardial ischaemia. Opioid receptors (μ-, δ-, κ-opioid receptors) have been shown to be significant triggers or mediators of IPC- or MPC-induced cardioprotection(Gross, 2003; Schultz et al., 1997). Several investigators have further shown that the reduction in infarct size induced by IPC or MPC was mediated by the activation of δ-opioid receptors in the heart to inhibit cardiomyocyte apoptosis in vivo (Okubo et al., 2004; Peart et al., 2003; Schultz et al., 1997).

  • Opioids and Acute Kidney Injury

    2021, Seminars in Nephrology
View all citing articles on Scopus

Please address all correspondence to: Garrett J. Gross, Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA

View full text